Key players in Schizophrenia Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Johnson & Johnson |
jnj.com (opens in a new tab) | 2,376 reports |
| 2 | Otsuka Pharmaceutical Co., Ltd. | — | 231 reports |
| 3 |  Bristol-Myers Squibb |
bms.com (opens in a new tab) | 627 reports |
| 4 |  Teva Pharmaceutical |
tevapharm.com (opens in a new tab) | 462 reports |
| 5 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
Also active in Schizophrenia Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Aurobindo Pharma |
|
| Macleods Pharmaceuticals | |
| Neurocrine Biosciences |
|
| Luye Pharma Group Ltd. |
|
| Zydus Lifesciences | |
| Accord Healthcare | |
| Mylan N.V. | |
| Vigonvita Life Sciences |
|
 Hikma Pharmaceuticals PLC |
|
| LB Pharmaceuticals Inc. |
|
| Intra-Cellular Therapies |
|
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Schizophrenia Drugs
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Bristol-Myers Squibb 11 active trials on ClinicalTrials.gov (opens in a new tab)
- Neurocrine Biosciences 6 active trials on ClinicalTrials.gov (opens in a new tab)
- Luye Pharma Group Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
- Otsuka Holdings Co Ltd 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Vigonvita Life Sciences 3 active trials on ClinicalTrials.gov (opens in a new tab)
- LB Pharmaceuticals Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Intra-Cellular Therapies 2 active trials on ClinicalTrials.gov (opens in a new tab)
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Schizophrenia Drugs reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Schizophrenia Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.